ATE173626T1 - Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis - Google Patents

Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis

Info

Publication number
ATE173626T1
ATE173626T1 AT95112104T AT95112104T ATE173626T1 AT E173626 T1 ATE173626 T1 AT E173626T1 AT 95112104 T AT95112104 T AT 95112104T AT 95112104 T AT95112104 T AT 95112104T AT E173626 T1 ATE173626 T1 AT E173626T1
Authority
AT
Austria
Prior art keywords
pancreatitis
treatment
producing
medicinal product
tocopheryl phosphate
Prior art date
Application number
AT95112104T
Other languages
English (en)
Inventor
Kazumi Ogata
Takahiro Sakaue
Shinya Ogino
Sachiko Matsuura
Rie Nagao
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE173626T1 publication Critical patent/ATE173626T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95112104T 1994-08-05 1995-08-01 Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis ATE173626T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18428294 1994-08-05

Publications (1)

Publication Number Publication Date
ATE173626T1 true ATE173626T1 (de) 1998-12-15

Family

ID=16150598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95112104T ATE173626T1 (de) 1994-08-05 1995-08-01 Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis

Country Status (8)

Country Link
US (1) US5650404A (de)
EP (1) EP0699440B1 (de)
KR (1) KR960006915A (de)
AT (1) ATE173626T1 (de)
CA (1) CA2152693A1 (de)
DE (1) DE69506197T2 (de)
ES (1) ES2124477T3 (de)
TW (1) TW317500B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703384B2 (en) * 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
CA2345079C (en) * 1998-09-23 2011-06-21 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
NZ520798A (en) * 2000-02-11 2004-05-28 Res Dev Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
WO2002026238A1 (en) * 2000-09-26 2002-04-04 Vital Health Sciences Pty Ltd. Phosphate derivative supplements
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
EP1420797A4 (de) 2001-07-27 2005-03-02 Vital Health Sciences Pty Ltd Hauttherapie unter verwendung von phosphatderivaten von elektronentransfermitteln
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
WO2005084678A1 (en) 2004-03-03 2005-09-15 Vital Health Sciences Pty Ltd Alkaloid formulations
ES2557475T3 (es) 2005-06-17 2016-01-26 Vital Health Sciences Pty Ltd. Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones
KR20080085839A (ko) * 2005-12-23 2008-09-24 바이탈 헬스 사이언시즈 피티와이 리미티드 사이토킨 조절 특성을 가진 화합물
WO2011094814A1 (en) 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
RU2425669C1 (ru) * 2010-04-13 2011-08-10 Общество С Ограниченной Ответственностью "Гамаветфарм" Средство для профилактики и лечения острого и хронического панкреатита
EP2685992A4 (de) 2011-03-15 2014-09-10 Phosphagenics Ltd Aminochinoline als kinasehemmer
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法
EP4034137A4 (de) * 2019-09-27 2023-09-20 Duke University Zusammensetzungen und verfahren zur prävention und behandlung von pankreatitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219295A (ja) * 1983-05-30 1984-12-10 Senjiyu Seiyaku Kk リン酸ジエステルまたはその塩およびそれらの製造法
JPS62145019A (ja) * 1985-12-19 1987-06-29 Senjiyu Seiyaku Kk 抗炎症剤
JPS62205091A (ja) * 1986-03-04 1987-09-09 Senjiyu Seiyaku Kk 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤
JP2526059B2 (ja) * 1987-04-28 1996-08-21 千寿製薬株式会社 抗潰瘍剤
PH25859A (en) * 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
JP2854631B2 (ja) * 1989-11-21 1999-02-03 千寿製薬株式会社 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤

Also Published As

Publication number Publication date
EP0699440B1 (de) 1998-11-25
ES2124477T3 (es) 1999-02-01
KR960006915A (ko) 1996-03-22
DE69506197T2 (de) 1999-04-15
DE69506197D1 (de) 1999-01-07
US5650404A (en) 1997-07-22
EP0699440A1 (de) 1996-03-06
CA2152693A1 (en) 1996-02-06
TW317500B (de) 1997-10-11

Similar Documents

Publication Publication Date Title
ATE173626T1 (de) Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis
DE69512925D1 (de) Ortho-substituierte aromatische ether und ihre verwendung in schmerzstillenden pharmazeutischen zusammensetzungen
MY117896A (en) Quinazoline derivatives
IL120584A (en) 1,2-diphenylpyrrole derivatives, use thereof for the manufacture of a medicament and pharmaceutical compositions containing the same
BG104561A (en) Aryl fused azapolycyclic compounds
ATE253918T1 (de) Verwendung von hymenialdisin und dessen derivaten zur herstellung therapeutischer mittel
SE0104334D0 (sv) Therapeutic agents
ATE523194T1 (de) Bis(thiohydrazidamide) in kombination mit taxol für die behandlung von krebs
ATE206926T1 (de) Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne
PT781766E (pt) Derivado heterociclico e medicamento
DE69400382D1 (de) Zusammensetzung zur Förderung des Lipidmetabolismus
MX9804226A (es) Derivados novedosos de 2,3,5-trimetil-4-hidroxianilida, su preparacion y su aplicacion de terapeutica.
ATE367387T1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
DE69428325D1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
ATE123944T1 (de) Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen.
ATE170852T1 (de) Benzolsulfonamid-derivate zur behandlung der blaseninstabilität
BG104983A (en) Aryl fused azapolycyclic compounds
FI935800A0 (fi) Antidepressiva och mot Parkisons sjukdom verksamma foereningar
ATE156359T1 (de) Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis
MX9605458A (es) Derivados de amida y su uso terapeutico.
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE69518159D1 (de) Mittel zur vorsorge und heilung von typ i allergischen krankheiten
DE69837334D1 (de) Heterozyclische verbindungen, ihr herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen
HUP0001773A2 (hu) Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények
HUP9900668A2 (hu) Szulfamidsavszármazékok, N-acil-szulfonamidok és szulfonil-karbamát-származékok alkalmazása lipoproteinszintet csökkentő gyógyászati készítmények előállítására

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties